Clinical Trials in Houston

Showing 13441-13460 of 15,366 trials

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

NCT00004025

RATIONALE: Vaccines made from a person's white blood cells combined with melanoma antigens may make the body build an immune response to tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill melanoma cells. Combining vaccine therapy with interleukin-2 may be an effective treatment for stage III or stage IV melanoma. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy with or without interleukin-2 in treating patients who have stage III or stage IV melanoma that cannot be surgically removed.

Melanoma (Skin)

Genzyme, a Sanofi Company36 participantsStarted Mar 1999

Boston, Massachusetts, United States • Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Exploratory Study of Pagoclone in Men With Premature Ejaculation.

NCT00370981

The purpose of this study is to evaluate pagoclone in the treatment of premature ejaculation.

Premature Ejaculation

Endo Pharmaceuticals100 participantsStarted Jul 2006

Homewood, Alabama, United States • San Diego, California, United States • Aurora, Colorado, United States +13 more locations

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Exploratory Study of Pagoclone in Men With Premature Ejaculation.

Find Trials by Condition in Houston

A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Vaccine Therapy in Treating Patients With Malignant Melanoma

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Eflornithine in Treating Patients With Bladder Cancer

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)

Tiotropium In Exercise

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554